SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Long Term Investor Alert: Lawsuit Against Directors Filed
An investor in shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) filed a lawsuit against directors of SciClone Pharmaceuticals, Inc. over alleged breaches of fiduciary duties in connection certain statements was announced.
View full press release